Augusti Mark A Has Sold $63,287 in Conformis Inc. [CFMS] Stock
On Jan. 04, Augusti Mark A divested U.S. $63,287 in shares of Conformis Inc.. The Pres, CEO sold 93,285 shares at a price per share of $0.68. The transaction decreased this specific insider’s holdings to 2,248,085 shares worth around $1.69 million at present. BTIG Research took its Conformis Inc. [CFMS] rating to the equivalent of […]
CrowdStrike Holdings Inc. [CRWD] Sees 20,000 Share Insider Sell From COO Black Colin
On Jan. 04, Black Colin divested U.S. $4,108,579 in shares of CrowdStrike Holdings Inc.. The COO sold 20,000 shares at a price per share of $205.43. The transaction decreased this specific insider’s holdings to 121,173 shares worth around $25.31 million at present. Another 320,000 shares were sold by Podbere Burt W., for more than $64,474,793 […]
Acceleron Pharma Inc. [XLRN] Insider Just Sold 2,056 Shares. Should You?
On Jan. 05, Veness Adam M divested U.S. $251,988 in shares of Acceleron Pharma Inc.. The SVP, GC, Sec. sold 2,056 shares at a price per share of $122.56. The transaction decreased this specific insider’s holdings to 16,163 shares worth around $1.98 million at present. Another 10,000 shares were sold by Kango Sujay, for more […]
GoDaddy Inc. [GDDY] Sees 3,488 Share Insider Sell From GC Kelly Nima
On Jan. 04, Kelly Nima divested U.S. $283,260 in shares of GoDaddy Inc.. The GC sold 3,488 shares at a price per share of $81.21. The transaction decreased this specific insider’s holdings to 64,192 shares worth around $5.15 million at present. Another 2,999 shares were sold by Bhutani Amanpal Singh, for more than $244,936 in […]
Insider Selling: Ionis Pharmaceuticals Inc. [IONS] EVP, Research Sells 195 Shares Worth $10,918
On Jan. 05, Swayze Eric divested U.S. $10,918 in shares of Ionis Pharmaceuticals Inc.. The EVP, Research sold 195 shares at a price per share of $55.99. The transaction decreased this specific insider’s holdings to 5,107 shares worth around $0.29 million at present. UBS launched its Ionis Pharmaceuticals Inc. [IONS] rating to the equivalent of […]
Evoqua Water Technologies Corp. [AQUA] Sees 112,500 Share Insider Sell From EVP, CHRO Webster Anthony
On Jan. 04, Webster Anthony divested U.S. $3,034,382 in shares of Evoqua Water Technologies Corp.. The EVP, CHRO sold 112,500 shares at a price per share of $26.97. The transaction decreased this specific insider’s holdings to 76,942 shares worth around $2.2 million at present. Robert W. Baird took its Evoqua Water Technologies Corp. [AQUA] rating […]
Independent Bank Group Inc. [IBTX] Insider Just Sold 30,000 Shares. Should You?
On Jan. 04, Brooks David R divested U.S. $1,879,009 in shares of Independent Bank Group Inc.. The COB, CEO, Pres sold 30,000 shares at a price per share of $62.63. The transaction decreased this specific insider’s holdings to 919,077 shares worth around $62.96 million at present. Truist launched its Independent Bank Group Inc. [IBTX] rating […]
Is that why Addex Therapeutics (ADXN) shares dropped earlier this morning?
A biotech firm, Addex Therapeutics Ltd (Nasdaq: ADXN), shares melted in the premarket as it dropped -21.23% to $10.23 after it revealed the pricing of an underwritten public offering of 6,000,000 shares at a price of approximately CHF1.47 per share or $10 per ADS. ADS represents the right to receive six shares of Addex. Before […]
Insider Selling: Exelixis Inc. [EXEL] EVP, Scientific Strategy, CSO Sells 65,000 Shares Worth $1,320,800
On Jan. 04, Lamb Peter divested U.S. $1,320,800 in shares of Exelixis Inc.. The EVP, Scientific Strategy, CSO sold 65,000 shares at a price per share of $20.32. The transaction decreased this specific insider’s holdings to 300,229 shares worth around $6.56 million at present. Barclays launched its Exelixis Inc. [EXEL] rating to the equivalent of […]
Cimarex Energy [XEC] Stock Gets Reiterated At KeyBanc. It’s Still Overweight
KeyBanc maintained its Cimarex Energy [XEC] rating to the equivalent of Overweight but changed the price target to $$46.0 from $42, in a research note dated 2021-01-07. That figure represents around a 5.89% premium from where the company’s shares closed on Wednesday. Other analysts also revised their coverage, with Trust’ analysts downgrading the shares from […]
